Límite 09 Oct 2022
Oferta Tecnológica
Ref.
TOSI20210928001
New compounds for efficient and safer cancer treatment available for license and research cooperation agreement
Researchers at a Slovenian research institute have discovered a new class of compounds for potential use in combinational chemotherapy treatments of cancer. Compounds display promising anticancer activity, along with a promise of an improved safety profile compared to established chemotherapeutics and they can be easily integrated into existing chemotherapy regimens. The partner sought is a pharmaceutical or biotechnological company for license and research cooperation agreement.